Patents by Inventor Victor Shashoua

Victor Shashoua has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070042962
    Abstract: Methods and compositions comprising peptide compounds are described to upregulate expression of telomerase in eukaryotic cells, tissues, and organs. Such methods and compositions are particularly useful in treating diseases, trauma, and conditions of the aging process.
    Type: Application
    Filed: February 3, 2003
    Publication date: February 22, 2007
    Inventors: David Adams, Victor Shashoua
  • Publication number: 20060019901
    Abstract: Peptide compounds and methods for upregulating expression of a gene encoding an antioxidative enzyme, such as superoxide dismutase or catalase, to counteract harmful oxidative effects of reactive oxygen species and other free radicals are described. The peptide compounds may be used to treat or prevent diseases and conditions characterized by undesirable elevation of reactive oxygen species and other free radicals, to upregulate AP-1 gene expression, and to treat pain. The peptide compounds may be used as components of pharmaceuticals and dietary supplements.
    Type: Application
    Filed: November 24, 2004
    Publication date: January 26, 2006
    Applicant: CereMedix, Inc.
    Inventor: Victor Shashoua
  • Publication number: 20050130902
    Abstract: The invention provides compositions comprising isolated peptide compounds, which upregulate expression of a gene encoding an antioxidative anzyme, such as superoxide dismutase or catalase, to counteract harmful oxidative effects of reactive oxygen species and other free radicals. The composition may be used to treat or prevent diseases and conditions characterized by undesirable elevation of reactive oxygen species and other free radicals.
    Type: Application
    Filed: May 17, 2002
    Publication date: June 16, 2005
    Inventor: Victor Shashoua
  • Publication number: 20050130881
    Abstract: Single amino acid compounds and methods for upregulating expression of a gene encoding an antioxidative enzyme, such as superoxide dismutase or catalase, to counteract harmful oxidative effects of reactive oxygen species and other free radicals are described. The single amino acid compounds may be used in compositions and methods to treat or prevent diseases and conditions characterized by undesirable elevation of reactive oxygen species and other free radicals.
    Type: Application
    Filed: May 24, 2002
    Publication date: June 16, 2005
    Inventor: Victor Shashoua
  • Publication number: 20050090446
    Abstract: Peptide compounds and methods for upregulating expression of a gene encoding an antioxidative enzyme, such as superoxide dismutase or catalase, to counteract harmful oxidative effects of reactive oxygen species and other free radicals are described. The peptide compounds may be used to treat or prevent diseases and conditions characterized by undesirable elevation of reactive oxygen species and other free radicals, to upregulate AP-1 gene expression, and to treat pain. The peptide compounds may be used as components of pharmaceuticals and dietary supplements.
    Type: Application
    Filed: November 11, 2004
    Publication date: April 28, 2005
    Applicant: CereMedix, Inc.
    Inventor: Victor Shashoua
  • Publication number: 20050004019
    Abstract: The invention relates to neuroprotective peptides which bind calcium and which are useful in treating stroke and other neurodegenerative diseases, as well as compositions containing such peptides. The peptides preferably are conjugated to or administered with a compound which facilitates delivery across the blood-brain barrier.
    Type: Application
    Filed: September 29, 2003
    Publication date: January 6, 2005
    Applicant: Protarga, Inc.
    Inventor: Victor Shashoua
  • Patent number: 6627601
    Abstract: The invention relates to neuroprotective peptides which bind calcium and which are useful in treating stroke and other neurodegenerative diseases, as well as compositions containing such peptides. The peptides preferably are conjugated to or administered with a compound which facilitates delivery across the blood-brain barrier.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: September 30, 2003
    Assignee: Protarga, Inc.
    Inventor: Victor Shashoua
  • Publication number: 20020025943
    Abstract: The invention provides compositions that include conjugates of a carrier molecule, preferably cis-docosahexaenoic acid, and 2′,3′-dideoxycytidine. The conjugates are useful in treating viral infections, especially retroviral infections, and particularly reservoirs of viral infection in peripheral T cells and central nervous system manifestations thereof.
    Type: Application
    Filed: September 6, 2001
    Publication date: February 28, 2002
    Inventors: Matthews O. Bradley, Charles S. Swindell, Nigel L. Webb, Victor Shashoua
  • Publication number: 20020010208
    Abstract: The invention provides conjugates of cis-docosahexaenoic acid and pharmaceutical agents useful in treating noncentral nervous system conditions. Methods for selectively targeting pharmaceutical agents to desired tissues are provided.
    Type: Application
    Filed: May 1, 2001
    Publication date: January 24, 2002
    Inventors: Victor Shashoua, Charles Swindell, Nigel Webb, Matthews Bradley
  • Publication number: 20010056116
    Abstract: The invention involves the formation of a prodrug from a fatty acid carrier and a neuroactive drug. The prodrug is stable in the environment of both the stomach and the bloodstream and may be delivered by ingestion. The prodrug passes readily through the blood brain barrier. Once in the central nervous system, the prodrug is hydrolyzed into the fatty acid carrier and the drug to release the drug.
    Type: Application
    Filed: July 9, 2001
    Publication date: December 27, 2001
    Inventor: Victor Shashoua
  • Publication number: 20010034035
    Abstract: The invention relates to neuroprotective peptides which bind calcium and which are useful in treating stroke and other neurodegenerative diseases, as well as compositions containing such peptides. The peptides preferably are conjugated to or administered with a compound which facilitates delivery across the blood-brain barrier.
    Type: Application
    Filed: March 16, 2001
    Publication date: October 25, 2001
    Inventor: Victor Shashoua